Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Interest Income Expense
Tandem Diabetes Care Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Interest Income Expense
$12.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Tandem Diabetes Care Inc's Interest Income Expense?
Interest Income Expense
12.2m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Interest Income Expense amounts to 12.2m USD.
What is Tandem Diabetes Care Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
130%
Over the last year, the Interest Income Expense growth was 130%.